← Leaderboards
Robert E Schwartz
Weill Medical Coll Of Cornell Univ
$8,769,705
Attributed
$12,750,249
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,750,249 · 10
By mechanism
R01$11,243,949 · 7
K08$780,737 · 1
R21$471,313 · 1
R03$254,250 · 1
Top collaborators
- James C Lo4 shared
- Alexander Ploss4 shared
- Shuibing Chen3 shared
- Jean Kyou Lim3 shared
- Stacey S Huppert2 shared
- Thomas Pietschmann2 shared
- Michael Jeffrey Vinikoor1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Martin F Shapiro$11,123,560
- Mohammad Arifuzzaman$410,664
- Justin Cross$1,226,942
- Shashi Kapadia$4,528,330
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionHepatocytePathway InteractionsPlayPhenotypeCessation Of LifeIn VivoSignal TransductionCell TypePluripotent Stem CellsStem CellsInsightVirus ReplicationPrimary Carcinoma Of The Liver CellsMetabolicMolecularAdultImpairmentAutomobile DrivingHepaticVirusCell LineCommunities
Grant awards (33)
Spatial omics to understanding HBV control in people with HIV coinfection$806,208
R01 · FY2025 · AI · contact PI
Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis$688,831
R01 · FY2025 · DK
Mechanisms of epithelial-mesenchymal crosstalk in intrahepatic biliary formation$663,039
R01 · FY2025 · DK · contact PI
Genetic Viral and Host Adaptations to Breach Species Barriers of HCV$531,385
R01 · FY2025 · AI
Mechanisms of epithelial-mesenchymal crosstalk in intrahepatic biliary formation$689,050
R01 · FY2024 · DK · contact PI
Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis$666,810
R01 · FY2024 · DK
Genetic Viral and Host Adaptations to Breach Species Barriers of HCV$577,427
R01 · FY2024 · AI
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte$366,120
R01 · FY2024 · DK · contact PI
Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis$690,036
R01 · FY2023 · DK
Decode the Impact of SARS-CoV-2 on Human Pancreas$422,571
R01 · FY2023 · DK
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte$381,375
R01 · FY2023 · DK · contact PI
Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells$375,047
R01 · FY2023 · CA · contact PI
Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis$93,772
R01 · FY2023 · DK
Decode the Impact of SARS-CoV-2 on Human Pancreas$422,571
R01 · FY2022 · DK
Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells$382,700
R01 · FY2022 · CA · contact PI
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte$381,375
R01 · FY2022 · DK · contact PI
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte$758,146
R01 · FY2021 · DK · contact PI
Decode the Impact of SARS-CoV-2 on Human Pancreas$440,068
R01 · FY2021 · DK
Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells$382,700
R01 · FY2021 · CA · contact PI
Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells$382,700
R01 · FY2020 · CA · contact PI
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte$381,375
R01 · FY2020 · DK · contact PI
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte$381,375
R01 · FY2020 · DK · contact PI
Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells$379,268
R01 · FY2019 · CA · contact PI
Identification of Hepatitis B Virus permissiveness factors$127,125
R03 · FY2019 · DK · contact PI
New Hepatocyte Model Systems to study Hepatitis B Virus Infection$159,508
K08 · FY2018 · DK · contact PI
Identification of Hepatitis B Virus permissiveness factors$127,125
R03 · FY2018 · DK · contact PI
New Hepatocyte Model Systems to study Hepatitis B Virus Infection$159,508
K08 · FY2017 · DK · contact PI
Impact of species-specific host responses on restriction of hepatotropic viruses$248,625
R21 · FY2016 · AI
New Hepatocyte Model Systems to study Hepatitis B Virus Infection$153,457
K08 · FY2016 · DK · contact PI
Impact of species-specific host responses on restriction of hepatotropic viruses$222,688
R21 · FY2015 · AI
New Hepatocyte Model Systems to study Hepatitis B Virus Infection$153,457
K08 · FY2015 · DK · contact PI
New Hepatocyte Model Systems to study Hepatitis B Virus Infection$1,350
K08 · FY2015 · DK · contact PI
New Hepatocyte Model Systems to study Hepatitis B Virus Infection$153,457
K08 · FY2014 · DK · contact PI